Fukuoka Wajiro, SoftBank and Kyushu Power helped pathology imaging system and software provider Medmain raise $10.3m in its second funding round.
Japan-based pathology software developer Medmain has secured ¥1.1bn ($10.3m) from investors including care provider Fukuoka Wajiro Hospital Group and subsidiaries of telecommunications and internet group SoftBank and electric utility Kyushu Power.
IHW Group, Hike Ventures, Innovations and Future Creation and unnamed angel investors also took part in the round. SoftBank invested through artificial intelligence fund Deepcore while Kyushu Power participated through its QTnet and Dogan Beta subsidiaries.
Founded in 2018, Medmain has developed a system called PidPort which uses AI…
